Cited by 247Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsNeurogenesis and neuroplasticity mechanisms

A 3D human brain–like tissue model of herpes-induced Alzheimer’s disease

Open access
Cairns, Dana M., Rouleau, Nicolas, Parker, Rachael N., Walsh, Katherine G., Gehrke, Lee, Kaplan, David L.·2020·Science Advances

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that causes cognitive decline, memory loss, and inability to perform everyday functions. Hallmark features of AD-including generation of amyloid plaques, neurofibrillary tangles, gliosis, and inflammation in the brain-are well defined; however, the cause of the disease remains elusive. Growing evidence implicates pathogens in AD development, with herpes simplex virus type I (HSV-1) gaining increasing attention as a potential causative agent. Here, we describe a multidisciplinary approach to produce physiologically relevant human tissues to study AD using human-induced neural stem cells (hiNSCs) and HSV-1 infection in a 3D bioengineered brain model. We report a herpes-induced tissue model of AD that mimics human disease with multicellular amyloid plaque-like formations, gliosis, neuroinflammation, and decreased functionality, completely in the absence of any exogenous mediators of AD. This model will allow for future studies to identify potential downstream drug targets for treating this devastating disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.aay8828

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a silk protein scaffold using HSV-1, researchers mimicked plaque formation, neuroinflammation, and decreased cell functionality without exogenous AD mediators.

    “They were able to mimic the plaque formation, neuroinflammation, and decreased functionality of the cells without the use of exogenous AD mediators.”
  • After plaque formation, the HSV-1 silk scaffold model can no longer be used to evaluate preventative strategies.

    “It should be noted that after plaque formation, the model can no longer be used to evaluate preventative strategies.”

    From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [136]

    The Results describe plaque-like formation in the 3D model and antiviral treatment given at infection or one day later, while the Discussion suggests the model may help develop treatment strategies. Neither section addresses whether the model can be used to evaluate preventative strategies after plaques have formed; searches for that timing-based limitation found no passage stating it. (LLM, conf=0.72)

    Experimental — accuracy not yet measured
  • Low-grade HSV-1 infection induced an AD-like phenotype in brain organoids derived from hiNSCs.

    “This work, furthermore, showed that low-grade HSV-1 infection induced an AD-like phenotype in brain organoids derived from hiNSCs (236).”
  • HSV-1 infection of human-induced neural stem cell lines in vitro induced gliosis and inflammation, including production of IL-1β, IL-6, and IFN-γ.

    “The authors showed that infecting human-induced neural stem cell (hiNSC) lines with HSV-1 in vitro induced gliosis and inflammation, including the production of pro-inflammatory cytokines such as IL-1β, IL-6, and IFN-γ.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cairns, D. M., Rouleau, N., Parker, R. N., Walsh, K. G., Gehrke, L., & Kaplan, D. L.
Affiliations
  • Tufts University (US)
  • Massachusetts Institute of Technology (US)
Corresponding author
Kaplan, David L.
Venue
Science Advances
Published
2020-05-08
Volume
6
Issue
19
Pages
eaay8828-eaay8828
ISSN
2375-2548 (ISSN-L)
OpenAlex
W3023103130
Cited by
247
References
63
Citations by year
2026: 17 · 2025: 30 · 2024: 44 · 2023: 35 · 2022: 40 · 2021: 52 · 2020: 29
FWCI
23.46
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
Funders
National Institutes of Health (R01NS092847)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
Alzheimer's disease, herpes simplex virus type 1, HSV-1 infection, amyloid plaques, gliosis, neuroinflammation
MeSH terms
Alzheimer Disease, Brain, Gliosis, Herpes Simplex, Humans, Amyloid beta-Peptides, Herpesvirus 1, Human, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review